Creighton University Medical Center-Bergan Mercy
Division of Surgical Oncology
7710 Mercy Rd
Omaha, Ne 68124

 

 

The CHI Health Creighton University Medical Center Peritoneal Neoplastic Disease program in Omaha was established in 2002 by CHI Health oncology surgeon Dr. Brian Loggie. In the early 90s, during his tenure at Wake Forest University Baptist Medical Center, Dr. Loggie’s frustration with the lack of treatment options for peritoneal cancer led him to develop a revolutionary treatment that provides hope for patients with peritoneal cancer, including those in the late stages.

Dr. Loggie’s expertise is in surgical oncology and the management and treatment of rare cancers has earned him a national and international reputation for his expertise in the field. Patients from all 50 states and several countries have been treated through the Peritoneal Neoplastic Disease program.

Cancers we treat

The Peritoneal Neoplastic Disease program staff treats individuals who have rare diseases as malignant peritoneal mesothelioma, cutaneous malignant melanoma, peritoneal carcinomatosis and malignant ascites, abdominopelvic and retroperitoneal sarcomas, pseudomyxoma peritonei, and management of complex primary, recurrent solid tumors and appendix neoplasms. Patients with more common underlying diseases such as colon cancer or ovarian cancer also are treated through the program.

Cytoreductive surgery and heated chemotherapy

Dr. Loggie pioneered the use of intraperitoneal heated chemotherapy (IPHC or HIPEC) and cytoreductive surgery. After cytoreductive surgery to remove all visible cancer tumors, during the same procedure the abdominal cavity is bathed for two hours with a chemotherapy agent which is heated to 106 degrees Fahrenheit. This process kills cancer cells that are not visible. Due to the complexity of the combined therapy of cytoreductive surgery and HIPEC, few surgeons are appropriately trained and experienced to offer this treatment option.

This two-pronged treatment option and has achieved better patient outcomes than either procedure alone. Data show patients undergoing this treatment live longer and have a better quality of life. The choice of chemotherapy drug also has played a significant role. In a study of mesothelioma patients conducted by Dr. Loggie, he concluded that Carboplatin is the preferred IPHC /HIPEC agent.

Schedule a conversation with a surgeon today!

HIPEC at Creighton Medical Center

HIPEC is an alternative and innovative method of delivering chemotherapy, which is commonly used to treat many types of cancer, to the body. Unlike traditional chemotherapy that is delivered intravenously, HIPEC delivers chemotherapy directly into the abdomen making it a good option for cancers that originated in or have spread to the abdominal cavity. How does HIPEC work? First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing

How does HIPEC work?

First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing First, your surgeon removes any visible tumors from the abdomen. Next, HIPEC delivers heated chemotherapy directly inside the abdomen to help destroy any remaining cancer cells and very small tumors that cannot be seen by the surgeon. This is because the chemotherapy circulates inside the abdomen, allowing it to reach more places. The goal of HIPEC is to prevent these cells from growing into new tumors and causing the cancer to return.

What are the benefits of HIPEC procedures?

  • HIPEC allows for a higher concentration of chemotherapy to be delivered into the abdomen more effectively and safer than standard chemotherapy, which is delivered intravenously.
  • This type of chemotherapy is best at killing cancer cells that are too small to be seen with the naked eye.
  • Chemotherapy delivered through HIPEC causes fewer side effects than intravenous chemotherapy. This is because the high concentrations of chemotherapy solution are unable to cross what is known as the peritoneal plasma barrier.
  • Experts say that pairing surgery and HIPEC together may be more beneficial than chemotherapy alone.

Am I a candidate for HIPEC?

Typical HIPEC patients are those with certain Stage IV abdominal cancers. Many are seeking an alternative to traditional chemotherapy or radiation therapy, as these options offer limited success treating advanced abdominal cancers. Patients also may have been told that no other treatment will work, but are still hoping to find a solution.